SMTL ID : 3efl.2 (1 other biounit)

Crystal structure of the VEGFR2 kinase domain in complex with motesanib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x 706: N-(3,3-dimethyl-2,3-dihydro-1H-indol-6-yl)-2-[(pyridin-4-ylmethyl)amino]pyridine-3-carboxamide(Non-covalent)

706.1: 18 residues within 4Å: Chain A: L.26, V.34, A.52, K.54, E.71, L.75, I.78, V.100, V.102, E.103, F.104, C.105, L.155, H.162, L.171, C.181, D.182, F.183 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:A.52, A:K.54, A:E.71, A:L.75, A:I.78, A:V.102, A:L.155, A:L.171, A:D.182, A:F.183 Hydrogen bonds: A:E.71, A:C.105, A:D.182, A:D.182 pi-Cation interactions: A:K.54

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tasker, A.S. et al., Discovery of Motesanib. To be Published

Release Date

2009-09-15

Peptides

Vascular endothelial growth factor receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Vascular endothelial growth factor receptor 2

Related Entries With Identical Sequence